E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/14/2015 in the Prospect News PIPE Daily.

HCi Viocare takes in $100,000 through private placement of its stock

Lone investor purchases 200,000 common shares at $0.50 per share

By Devika Patel

Knoxville, Tenn., Oct. 14 – HCi Viocare completed a $100,000 private placement of stock with a single investor on Oct. 7, according to an 8-K filed Wednesday with the Securities and Exchange Commission.

The company sold 200,000 common shares at $0.50 apiece. The price per share reflects a 33.33% discount to the Oct. 6 closing share price of $0.75.

The development-stage company is based in Glasgow. It is working to create a chain of prosthetics and orthotics and diabetic foot clinics in Europe and the Middle East and developing a portfolio of biomedical technologies in the diabetic foot, prosthetics and orthotics and other health and wellbeing areas.

Issuer:HCi Viocare
Issue:Common stock
Amount:$100,000
Shares:200,000
Price:$0.50
Warrants:No
Settlement date:Oct. 7
Stock symbol:OTCBB: VICA
Stock price:$0.75 at close Oct. 6
Market capitalization:$155.87 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.